Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1149-1154

  Kuang, Yan ^a,b   Cai, Jing ^a   Li, Donglin ^a   Han, Qin ^a   Cao, Jin ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cell proliferation; Cisplatin resistance; Dicer; EZH2; Migration; Ovarian cancer

Indexed keywords

CISPLATIN; DICER; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EZH2;

ARTICLE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ELISA KIT; ENZYME REPRESSION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA ISOLATION; WESTERN BLOTTING;

EID: 84874416559     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1158     Document Type: Article

References (24)

1. Wahid F, Shehzad A, Khan T, et al: Micrornas: Synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 1803: 1231-1243, 2010.
2. Calin GA, Liu CG, Sevignani C, et al: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760, 2004.
3. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
4. Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003.
5. Roldo C, Missiaglia E, Hagan JP, et al: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006.
6. Bernstein E, Caudy AA, Hammond SM, et al: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366, 2001.
7. Kumar MS, Lu J, Mercer KL, et al: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
8. Mezzanzanica D, Bagnoli M, De Cecco L, et al: Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol 42: 1262-1272, 2010.
9. Merritt WM, Lin YG, Han LY, et al: Dicer, drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650, 2008.
10. Simon JA and Lange CA: Roles of the EZH2 histone methyl transferase in cancer epigenetics. Mutat Res 647: 21-29, 2008.
11. Taniguchi H, Jacinto FV, Villanueva A, et al: Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene 31: 1988-1994, 2012.
12. Fang J, Zhang MX and Li QL: Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and invasion in cervical cancer. Am J Med Sci 342: 198-204, 2011.
13. Guo JF, Cai J, Yu LL, et al: EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo. Cancer Science 102: 530-539, 2011.
14. Noh H, Hong S, Dong Z, et al: Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression. Genes Cancer 2: 140-150, 2011.
15. Tang KF, Song GB, Shi YS, et al: Dicer knockdown induces fibronectin-1 expression in HEK293T cells via induction of Egr1. Biochim Biophys Acta 1800: 380-384, 2010.
16. Han L, Zhang A, Zhou X, et al: Downregulation of Dicer enhances tumor cell proliferation and invasion. Int J Oncol 37: 299-305, 2010.
17. Kumar MS, Lu J, Mercer KL, et al: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007.
18. McLoughlin HS, Fineberg SK, Ghosh LL, et al: Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience 223: 285-295, 2012.
19. Faggad A, Budczies J, Tchernitsa O, et al: Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression. J Pathol 220: 382-391, 2010.
20. Bu Y, Lu C, Bian C, et al: Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin. Oncol Rep 21: 13-17, 2009.
21. Tokumaru S, Suzuki M, Yamada H, et al: Let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29: 2073-2077, 2008.
22. Wiesen JL and Tomasi TB: Dicer is regulated by cellular stresses and interferons. Mol Immunol 46: 1222-1228, 2009.
23. Hu S, Yu L, Li Z, Shen Y, et al: Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther 10: 788-795, 2010.
24. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔ C (T)) Method. Methods 25: 402-408, 2001.